简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2017-11-10 11:50 Patient Safety Movement Foundation and Dubai Healthcare City Authority Launch First Patient Safety Movement in the Middle East
2017-11-10 09:54 Alexion Employees Volunteer Together to Enhance Their Local Communities during Second Annual Global Day of Service
2017-11-09 14:24 LMD’s Highlights New Temperature Measurement Applications for V-Sensor-Enabled Smartphones
2017-11-09 09:56 Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases
2017-11-08 14:11 Progenity Announces Closing of $125 Million Financing for Prenatal-Women’s Health Genetics and Gastrointestinal/Inflammatory Bowel Disease Precision Medicine
2017-11-07 09:51 Takeda’s Dengue Vaccine Candidate Associated with Reduced Incidence of Dengue in Children and Adolescents; New 18-Month Interim Phase 2 Data Published in The Lancet Infectious Diseases
2017-11-07 09:49 Efficacy and safety maintained in patients who switched from Humira® to biosimilar Cyltezo®
2017-11-06 18:32 Takeda to Showcase Data That May Reshape the Future of Blood Cancer Treatments During 59th American Society of Hematology Annual Meeting
2017-11-03 14:17 AltemiaTM Achieves Successful Clinical Results in Pediatric Patients with Sickle Cell Disease (SCD)
2017-11-03 09:48 Boehringer Ingelheim and Dicerna Announce Collaboration to Develop Novel Treatments for Chronic Liver Diseases including Nonalcoholic Steatohepatitis (NASH)
2017-11-03 09:46 Philip Morris International Outlines Its Scientific Assessment Program and Results for Its Electronically Heated Tobacco Product (IQOS) in Latest Scientific Update for Smoke-Free Products
2017-11-02 18:37 Takeda Reports First Half FY2017 Results
2017-11-02 13:55 PMC Group International Announces Acquisition of Pharma Company in India
2017-10-31 15:34 GRAMINEX L.L.C. expands its partnership with IDIPharma after clinical study publication.
2017-10-31 09:54 Boehringer Ingelheim expands collaboration with Sarah Cannon Research Institute to investigate novel immuno-oncology combination therapy
2017-10-30 10:51 Efficacy and Safety Results from Second Phase III Trial (RADIANCE™ Part B) of Oral Ozanimod Versus an Active Comparator in Relapsing Multiple Sclerosis Presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting
2017-10-30 10:43 Efficacy and Safety Results from First Phase III Trial of Oral Ozanimod (SUNBEAM™) Versus an Active Comparator in Relapsing Multiple Sclerosis Presented at MSParis2017 – 7th Joint ECTRIMS – ACTRIMS Meeting
2017-10-26 09:44 Janssen’s New Darunavir-Based Single Tablet Regimen SYMTUZA® Shows Positive Outcome in Treatment of Antiretroviral-Naïve HIV Patients
2017-10-25 14:02 ABEC 4,000 Liter Single-Use Bioreactor to Expand Emergent BioSolutions Manufacturing Capability
2017-10-24 09:22 Hallstar’s New Photostabilizer, AvoBrite®, Solves Customers’ Regulatory Challenges While Delivering Outstanding Photoprotection

Business Wire Weibo

Press Releases

Latest Releases